Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Threatened miscarriage Age: Adult |
Dose: Oral – 5 mg Frequency: three times daily Duration: 5-7 days |
|
Indication: Recurrent miscarriage Age: Adult Condition: as soon as pregnancy confirmed |
Dose: Oral – 5-10 mg Frequency: three times daily Duration: at least one month after the critical period |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- May take with or without food
- Take as prescribed
Side Effect
- GI disturbances
- appetite/weight change
- fluid retention
- oedema
- acnes
- skin rash
- urticaria
- depression
- headache
- fever
- fatigue
- breast changes
- hirsutism
- changes in libido
- altered menstrual cycles or irregular menstrual bleeding (rare)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Carbamazepine, Griseofulvin, Phenobarbital, Phenytoin, Rifampicin
|
Enhanced clearance
|
|
Ketoconazole
|
May increase bioavailability of progesterone
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Thrombophleobitis
|
Risk of blood clots
|
|
Undiagnosed Vaginal Bleeding
|
May mask serious conditions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.